Ajooni Biotech Ltd Stock Price Today (NSE: AJOONI)
Fundamental Score
Ajooni Biotech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Ajooni Biotech Ltd share price today is ₹4.00, down 0.50% on NSE/BSE as of 31 July 2026. Ajooni Biotech Ltd (AJOONI) is a Small-cap company in the Animal Feed sector with a market capitalisation of ₹71.65 (Cr). The 52-week high for AJOONI share price is ₹5.94 and the 52-week low is ₹3.40. At a P/E ratio of 16.59x, AJOONI is currently trading below its industry average P/E of 21.96x. The company has a Return on Equity (ROE) of 4.82% and a debt-to-equity ratio of 0.19.
Ajooni Biotech Ltd Share Price Chart — NSE/BSE Historical Performance
Ajooni Biotech Ltd share price chart: 7.24% return over the past month. 52-week high ₹5.94, 52-week low ₹3.40.
Ajooni Biotech Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹4.03 | ₹4.07 | ₹3.97 | ₹4.00 | 97.60K (Cr) | |
| ₹3.99 | ₹4.12 | ₹3.91 | ₹4.02 | 4.85L (Cr) | |
| ₹3.92 | ₹4.05 | ₹3.90 | ₹3.96 | 1.69L (Cr) | |
| ₹4.04 | ₹4.04 | ₹3.92 | ₹3.94 | 69.31K (Cr) | |
| ₹4.10 | ₹4.12 | ₹3.95 | ₹3.97 | 3.42L (Cr) | |
| ₹3.90 | ₹4.22 | ₹3.90 | ₹4.03 | 6.60L (Cr) | |
| ₹4.02 | ₹4.08 | ₹3.94 | ₹3.95 | 3.35L (Cr) | |
| ₹4.24 | ₹4.30 | ₹4.20 | ₹4.24 | 4.57L (Cr) | |
| ₹4.22 | ₹4.25 | ₹4.10 | ₹4.20 | 3.76L (Cr) | |
| ₹4.25 | ₹4.25 | ₹4.12 | ₹4.14 | 1.93L (Cr) |
Ajooni Biotech Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹3.72 | ₹4.39 | ₹3.60 | ₹4.00 | +7.53% | |
| ₹4.18 | ₹4.18 | ₹3.40 | ₹3.67 | -12.20% | |
| ₹4.30 | ₹4.42 | ₹4.02 | ₹4.15 | -3.49% | |
| ₹3.88 | ₹4.50 | ₹3.88 | ₹4.20 | +8.25% | |
| ₹4.24 | ₹4.75 | ₹3.67 | ₹3.84 | -9.43% | |
| ₹4.65 | ₹5.50 | ₹4.14 | ₹4.43 | -4.73% | |
| ₹4.40 | ₹4.40 | ₹3.55 | ₹3.89 | -11.59% | |
| ₹4.78 | ₹4.89 | ₹4.17 | ₹4.31 | -9.83% | |
| ₹5.15 | ₹5.32 | ₹4.16 | ₹4.83 | -6.21% | |
| ₹5.27 | ₹5.29 | ₹5.05 | ₹5.17 | -1.90% | |
| ₹5.40 | ₹5.94 | ₹5.07 | ₹5.27 | -2.41% | |
| ₹5.50 | ₹5.94 | ₹5.01 | ₹5.39 | -2.00% |
AI Research Briefing
Powered by Gemini · 2026-04-17
Microcap animal feed company with wafer-thin margins and execution risk.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search.
CORE STORY (THE REAL GAME)
Commoditized animal feed play. Ajooni is trying to scale in a fragmented market, but lacks a real moat. It's a volume game with low margins.
- ₹47.52 crore order win
- New plant commissioned
- Animal feed market growing at 6.6% CAGR
- Consistent order flow
- Raw material cost stabilization
- Successful capacity utilization
- Microcap liquidity risk
- Negative free cash flow [cite:]
- Low promoter holding at 26.89%
No FII/DII interest. Promoter holding stable [cite:]
Indian animal feed market projected to grow, driven by rising protein demand.
Secured order worth Rs 47.52 crore from an existing valued customer.
Negative free cash flow of ₹-10.62 Cr [cite:]
Need to see consistent order execution and positive cash flow. Until then, it's a show-me story.
Primary Thesis Risk
Inability to convert sales into free cash flow will kill the story.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Ajooni Biotech Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Ajooni Biotech Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AJOONI across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Attractive Valuation (P/E: 16.59 vs Industry: 21.96)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (107.11%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (29.12% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (67.84% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (63.48% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.19)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (8.85x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (4.82%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.49%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (3.43%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-38.31%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Negative Free Cash Flow (₹-30.82 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (26.89%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Ajooni Biotech Ltd vs Animal Feed Peers
Peer Comparison - Animal Feed
Compare Ajooni Biotech Ltd with 7 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
44.4/100 | ₹4.00₹4 | ₹71.65₹71.65 | 16.59Average 16.6 Average | 4.82%Poor 4.82% Poor | 6.49%Poor 6.49% Poor | 0.19Excellent 0.2 Excellent | 63.48%Excellent 63.48% Excellent | 29.12%Excellent 29.12% Excellent | 0.00% | |
Avanti Feeds LtdAvanti Feeds Lt... AVANTIFEED • 512573 | 53.6/100 | ₹899.60₹900 | ₹13479.58₹13479.58 | 21.96Average 22.0 Average | 20.17%Excellent 20.17% Excellent | 25.93%Excellent 25.93% Excellent | 0.00Excellent 0.0 Excellent | 13.74%Good 13.74% Good | 8.15%Good 8.15% Good | 0.91% |
Godrej Agrovet LtdGodrej Agrovet ... GODREJAGRO • 540743 | 52.7/100 | ₹556.80₹557 | ₹11077.76₹11077.76 | 24.03Average 24.0 Average | 20.89%Excellent 20.89% Excellent | 19.16%Good 19.16% Good | 0.77Good 0.8 Good | 8.00%Good 8.00% Good | 10.30%Good 10.30% Good | 1.91% |
Mukka Proteins LtdMukka Proteins ... MUKKA • 544135 | 46.1/100 | ₹22.54₹23 | ₹702.29₹702.29 | 13.49Average 13.5 Average | 11.08%Average 11.08% Average | 11.61%Average 11.61% Average | 1.56Average 1.6 Average | 52.61%Excellent 52.61% Excellent | 19.14%Excellent 19.14% Excellent | 0.00% |
Kse LtdKse Ltd... KSE • 519421 | 32.6/100 | ₹2328.85₹2329 | ₹592.96₹592.96 | 7.06Average 7.1 Average | 26.01%Excellent 26.01% Excellent | 33.56%Excellent 33.56% Excellent | 0.07Excellent 0.1 Excellent | -4.88%Poor -4.88% Poor | 1.72%Average 1.72% Average | 4.32% |
Shivansh Finserve LtdShivansh Finser... SHIVA • 544165 | 38.6/100 | ₹12.01₹12 | ₹178.36₹178.36 | 29.43Average 29.4 Average | 15.73%Good 15.73% Good | 16.83%Good 16.83% Good | 0.50Excellent 0.5 Excellent | — — | — — | 0.00% |
Narmada Agrobase LtdNarmada Agrobas... NARMADA • 543643 | 42.2/100 | ₹17.02₹17 | ₹135.36₹135.36 | 35.07Average 35.1 Average | 6.70%Poor 6.70% Poor | 8.95%Poor 8.95% Poor | 0.17Excellent 0.2 Excellent | 40.30%Excellent 40.30% Excellent | 5.93%Good 5.93% Good | 0.00% |
Mayank Cattle Food LtdMayank Cattle F... MCFL • 544106 | 42/100 | ₹212.05₹212 | ₹116.13₹116.13 | 19.29Average 19.3 Average | 17.17%Good 17.17% Good | 15.85%Good 15.85% Good | 1.05Average 1.1 Average | 52.92%Excellent 52.92% Excellent | 16.74%Excellent 16.74% Excellent | 0.00% |
Top Animal Feed Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Avanti Feeds Ltd share price13479.58 Cr
- Godrej Agrovet Ltd share price11077.76 Cr
- Mukka Proteins Ltd share price702.29 Cr
- Kse Ltd share price592.96 Cr
- Shivansh Finserve Ltd share price178.36 Cr
Ajooni Biotech Ltd PE Ratio History
Historical price-to-earnings ratio for AJOONI — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.25 | ₹7.77 | 31.1x |
| FY 2023 | ₹1.51 | ₹5.64 | 3.7x |
| FY 2022 | ₹0.16 | ₹5.51 | 33.8x |
| FY 2021 | ₹0.06 | ₹11.13 | 193.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Ajooni Biotech Ltd Quarterly Performance
Latest quarterly metrics for AJOONI — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
107.11%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-38.31%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
29.12%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
63.48%
Compounded annual net profit growth over 5 years
Ajooni Biotech Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AJOONI — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Ajooni Biotech Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Ajooni Biotech Ltd (AJOONI) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Ajooni Biotech Ltd
About AJOONI (Ajooni Biotech Ltd)
Ajooni Biotech Ltd is a pioneering force in the Indian animal feed industry, dedicated to enhancing livestock health and productivity through innovative and nutritionally superior ...feed solutions. With a strong commitment to quality and sustainability, Ajooni Biotech formulates specialized feed products tailored to meet the unique dietary needs of various livestock species. They meticulously select high-quality ingredients, ensuring optimal nutrient content and digestibility to support healthy growth, efficient milk production, and overall well-being in animals. Their dedication extends beyond just production as they strive to create environmentally responsible practices. The company’s diverse product range includes premium cattle feed pellets crafted with precision, nutritious supplements enriched with essential vitamins and minerals, and specialized feed options for other livestock. Ajooni Biotech continually invests in research and development, collaborating with animal nutrition experts to stay at the forefront of industry advancements. This commitment allows them to refine existing formulas and introduce novel feed solutions that address specific challenges faced by farmers and livestock owners. It is also their desire to become more well known. Ajooni Biotech operates with a deep understanding of the crucial role animal feed plays in the overall livestock ecosystem and the livelihood of farmers. They prioritize building strong relationships with their customers, offering expert guidance and support to optimize feeding practices. Through its unwavering focus on quality, innovation, and customer service, Ajooni Biotech is dedicated to empowering livestock farmers and contributing to a more sustainable and prosperous animal agriculture sector. The goal is to keep livestock healthy through high quality and specialized feeds.
Company Details
Key Leadership
AJOONI Share Price: Frequently Asked Questions
What is the current share price of Ajooni Biotech Ltd?
Ajooni Biotech Ltd (AJOONI) trades at ₹4.00 on NSE. Market cap ₹71.65 (Cr). Educational data only.
What is the P/E ratio of Ajooni Biotech Ltd?
Ajooni Biotech Ltd has a P/E of 16.59x vs industry average 21.96x.
What is the Bull Run score for Ajooni Biotech Ltd?
Ajooni Biotech Ltd has a Bull Run score of 44.4/100 based on 25+ financial parameters.
Does Ajooni Biotech Ltd pay dividends?
Ajooni Biotech Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Ajooni Biotech Ltd?
Ajooni Biotech Ltd has ROE of 4.82%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Ajooni Biotech Ltd?
Ajooni Biotech Ltd has debt-to-equity of 0.19.
Is Ajooni Biotech Ltd a good investment?
Bull Run gives Ajooni Biotech Ltd a score of 44.4/100. This is not investment advice — consult a SEBI-registered advisor.